Go Deep
3B Blackbio Dx Limited
3B Blackbio Dx Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 22,855 | 23.8 | 4.18 | 0.01 | 1,580.90 |
| Sep 2026 | 22,855 | 23.8 | 4.18 | 0.01 | 1,580.90 |
| Sep 2026 | 22,619 | 24.5 | 4.30 | 0.01 | 1,625.10 |
| Sep 2026 | 22,180 | 24.4 | 4.18 | 0.01 | 1,622.70 |
| Sep 2026 | 22,180 | 24.4 | 4.18 | 0.01 | 1,622.70 |
| Oct 2026 | 21,955 | 25.8 | 4.40 | 0.01 | 1,710.40 |
| Oct 2026 | 22,359 | 24.8 | 4.24 | 0.01 | 1,646.80 |
| Oct 2026 | 22,359 | 24.8 | 4.24 | 0.01 | 1,646.80 |
| Oct 2026 | 22,359 | 24.8 | 4.24 | 0.01 | 1,646.80 |
| Oct 2026 | 22,306 | 24.8 | 4.24 | 0.01 | 1,646.80 |
| Oct 2026 | 22,305 | 25.0 | 4.24 | 0.01 | 1,646.80 |
| Oct 2026 | 22,482 | 24.7 | 4.18 | 0.01 | 1,624.70 |
| Oct 2026 | 22,690 | 23.9 | 4.06 | 0.01 | 1,575.10 |
| Oct 2026 | 21,372 | 24.5 | 4.16 | 0.01 | 1,615.50 |
| Oct 2026 | 21,644 | 23.2 | 3.94 | 0.01 | 1,530.00 |
| Oct 2026 | 21,408 | 24.1 | 4.08 | 0.01 | 1,586.40 |
| Oct 2026 | 21,408 | 24.1 | 4.08 | 0.01 | 1,586.40 |
| Oct 2026 | 20,999 | 24.1 | 4.08 | 0.01 | 1,586.40 |
| Oct 2026 | 20,999 | 24.1 | 4.08 | 0.01 | 1,586.40 |
| Oct 2026 | 20,907 | 24.8 | 4.14 | 0.01 | 1,609.40 |
| Oct 2026 | 21,282 | 23.1 | 3.91 | 0.01 | 1,519.60 |
| Oct 2026 | 21,450 | 22.3 | 3.88 | 0.01 | 1,467.10 |
3B Blackbio Dx Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 334,908,000.0 | 354,341,000.0 | 503,473,000.0 | 339,021,000.0 |
| Net Profit | 95,319,000.0 | 95,551,000.0 | 217,296,000.0 | 147,119,000.0 |
| EPS | 11.1 | 11.4 | 25.3 | 17.6 |
3B Blackbio Dx Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,419,181,000.0 | 964,686,000.0 | 741,247,000.0 | 618,360,000.0 | — |
| Net Profit | 599,298,000.0 | 476,910,000.0 | 327,349,000.0 | 259,370,000.0 | — |
| EPS | 69.9 | 55.7 | 37.5 | 30.3 | — |
3B Blackbio Dx Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 3,779,953,000.0 | 2,957,184,000.0 | 2,481,047,000.0 | 2,140,586,000.0 | — |
| Total Liabilities | 463,566,000.0 | 247,134,000.0 | 226,305,000.0 | 181,478,000.0 | — |
| Total Equity | 3,243,819,000.0 | 2,684,223,000.0 | 2,230,495,000.0 | 1,932,565,000.0 | — |
Owes vs Owns
3B Blackbio Dx Limited owed ₹0.12 for every ₹1 it owned in Mar 2026, up from ₹0.08 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.12× | 0.08× | 0.09× | 0.08× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
3B Blackbio Dx Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 26.3%Receivables 13.3%Inventory 4.9%Fixed assets (tangible) 5.8%Intangible assets 1.5%Long-term investments 41.7%Other assets 6.5%
How it's funded — Mar 2026
Long-term debt 0.8%Payables 1.8%Other liabilities 9.6%Shareholders' equity 87.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 99.6 | 67.9 | 61.5 | 58.5 |
| Receivables | 50.1 | 36.5 | 36.2 | 33.9 |
| Inventory | 18.4 | 8.7 | 8.4 | 8.0 |
| Fixed assets (tangible) | 21.9 | 19.0 | 7.3 | 7.9 |
| Intangible assets | 5.7 | 0.7 | 0.0 | 0.0 |
| Long-term investments | 157.7 | 0.0 | 117.3 | 0.0 |
| Other assets | 24.6 | 162.8 | 17.3 | 105.7 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 1.1 |
| Long-term debt | 3.1 | 0.3 | 0.8 | 0.9 |
| Payables | 6.9 | 2.0 | 3.9 | 3.4 |
| Other liabilities | 36.3 | 22.4 | 17.9 | 12.7 |
| Shareholders' equity | 331.6 | 271.0 | 225.5 | 195.9 |
| Net tangible assets | 318.7 | 267.7 | 223.0 | 193.3 |
3B Blackbio Dx Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 524,759,000.0 | 433,565,000.0 | 269,511,000.0 | 202,844,000.0 | — |
| Investing Activities | -235,926,000.0 | -338,461,000.0 | -203,189,000.0 | 147,329,000.0 | — |
| Financing Activities | -5,244,000.0 | -32,193,000.0 | -36,253,000.0 | -50,067,000.0 | — |